The Minister for Jobs, Enterprise and Innovation Richard Bruton TD today announced that Neuromod Devices will create an additional 50 jobs for Dublin over the coming years. The announcement came as Neuromod Devices launched mutebutton™ a new device for the treatment of Tinnitus.
Neuromod Devices is headquartered in NovaUCD, the Centre for New Ventures and Entrepreneurs at UCD.
Neuromod Devices plan to achieve the creation of 50 new jobs over the next five years in Dublin. These highly specialised roles will be key in supporting its global growth targets to become a leading global provider of non-surgical neuromodulation treatments for chronic conditions.
Last night Enterprise Ireland, Irish Medical Devices Association (IMDA) and IDA Ireland announced Neuromod Devices Ltd as winner of the Emerging Medical Company of the Year Award 2014-2015 at the 8th annual Medical Industry Excellence Awards 2014.
Mutebutton™ is an innovative, clinically proven, self-administered treatment designed to alleviate the symptoms of chronic tinnitus sufferers. mutebutton™ is the culmination of over four years of research and development since the company was first founded in 2010 by CEO, Dr Ross O’Neill.
Minister Bruton said: “A key part of our Action Plan for Jobs is turning good ideas into good jobs. Over the past decade we have invested heavily in Government-supported research and innovation – the challenge we have been trying to address in the past three years is to build on that to create commercial ideas and ultimately jobs. Today Neuromod is announcing that it is creating an extra 50 high-end jobs in Dublin as a result of a product it has created through innovation it has carried out – this is a great example of what we are trying to achieve. I congratulate Neuromod Devices on its achievements and wish Ross and the team every success in the coming years.”
Dr Ross O’Neill, CEO, Neuromod Devices Ltd said: “I am delighted to announce the launch of a revolutionary new treatment for tinnitus sufferers, a condition which has lacked sufficient treatment to date despite affecting 1 in 10 of us. After four years of research and development, today Neuromod Devices is positioned to meet the unmet needs of tinnitus patients’ globally, with the launch of the mutebutton™ device. I am immensely proud of what we have achieved as a small Irish SME, in just four years and this is in no small part thanks to the state support we have received from Enterprise Ireland, NovaUCD and the NDRC.”
On winning the Emerging Medical Company of the Year Award 2014-2015 Dr O’Neill said: “It is an honour to be awarded the Emerging Company of the Year by the IMDA, especially in Ireland where we have such a thriving medical technology sector which employs 25,000 people nationwide and accounts for €8bn in exports.
“As an emerging company, today we are also proud to announce the launch of our mutebutton™ multisensory tinnitus treatment, the opening of The Neuromod Clinic™ and the creation of 50 new jobs. We appreciate the ongoing support of IMDA, IBEC and agencies like Enterprise Ireland which enable global innovation in Ireland and help to position Irish companies like Neuromod Devices for global success. We are truly honoured.”